DK0984787T3 - Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer - Google Patents

Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer

Info

Publication number
DK0984787T3
DK0984787T3 DK98925774T DK98925774T DK0984787T3 DK 0984787 T3 DK0984787 T3 DK 0984787T3 DK 98925774 T DK98925774 T DK 98925774T DK 98925774 T DK98925774 T DK 98925774T DK 0984787 T3 DK0984787 T3 DK 0984787T3
Authority
DK
Denmark
Prior art keywords
molecular weight
low molecular
prevention
treatment
brain edema
Prior art date
Application number
DK98925774T
Other languages
English (en)
Inventor
Veronique Mary
Jeremy Pratt
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0984787T3 publication Critical patent/DK0984787T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK98925774T 1997-05-28 1998-05-25 Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer DK0984787T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706551A FR2763849B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
PCT/FR1998/001035 WO1998053834A1 (fr) 1997-05-28 1998-05-25 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux

Publications (1)

Publication Number Publication Date
DK0984787T3 true DK0984787T3 (da) 2003-02-03

Family

ID=9507336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98925774T DK0984787T3 (da) 1997-05-28 1998-05-25 Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer

Country Status (24)

Country Link
US (1) US6579858B1 (da)
EP (1) EP0984787B1 (da)
JP (1) JP2002502387A (da)
KR (1) KR100562425B1 (da)
CN (1) CN1223351C (da)
AT (1) ATE225181T1 (da)
AU (1) AU742995B2 (da)
BR (1) BR9809180A (da)
CA (1) CA2290682A1 (da)
DE (1) DE69808455T2 (da)
DK (1) DK0984787T3 (da)
ES (1) ES2182321T3 (da)
FR (1) FR2763849B1 (da)
IL (2) IL132670A0 (da)
MA (1) MA24554A1 (da)
NO (1) NO317003B1 (da)
NZ (1) NZ501366A (da)
PE (1) PE73099A1 (da)
PT (1) PT984787E (da)
RU (1) RU2195287C2 (da)
TN (1) TNSN98072A1 (da)
TW (1) TW546141B (da)
WO (1) WO1998053834A1 (da)
ZA (1) ZA984433B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787329B1 (fr) * 1998-12-17 2001-02-09 Aventis Pharma Sa Nouvelle application therapeutique des heparines de bas poids moleculaire
JP2005505537A (ja) * 2001-08-28 2005-02-24 レオ・ファーマ・アクティーゼルスカブ 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013092C1 (ru) * 1989-02-27 1994-05-30 Дагестанский государственный медицинский институт Способ лечения отека мозга при туберкулезном менингоэнцефалите

Also Published As

Publication number Publication date
PE73099A1 (es) 1999-10-21
AU742995B2 (en) 2002-01-17
ATE225181T1 (de) 2002-10-15
IL132670A (en) 2010-05-31
BR9809180A (pt) 2000-08-01
CN1223351C (zh) 2005-10-19
IL132670A0 (en) 2001-03-19
WO1998053834A1 (fr) 1998-12-03
RU2195287C2 (ru) 2002-12-27
NO995539D0 (no) 1999-11-12
NO995539L (no) 1999-11-12
DE69808455D1 (de) 2002-11-07
MA24554A1 (fr) 1998-12-31
TW546141B (en) 2003-08-11
AU7776098A (en) 1998-12-30
PT984787E (pt) 2003-01-31
DE69808455T2 (de) 2003-07-03
FR2763849B1 (fr) 2000-09-15
US6579858B1 (en) 2003-06-17
CN1257429A (zh) 2000-06-21
TNSN98072A1 (fr) 2005-03-15
KR100562425B1 (ko) 2006-03-17
KR20010013073A (ko) 2001-02-26
FR2763849A1 (fr) 1998-12-04
EP0984787B1 (fr) 2002-10-02
EP0984787A1 (fr) 2000-03-15
ZA984433B (en) 1998-12-28
ES2182321T3 (es) 2003-03-01
JP2002502387A (ja) 2002-01-22
NO317003B1 (no) 2004-07-19
CA2290682A1 (fr) 1998-12-03
NZ501366A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
DK0786991T3 (da) Polyaminforbindelsre til behandling af proliferative karsygdomme
DK0888330T3 (da) Fremgangsmåder til behandling eller forebyggelse af interstitiel cystitis
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
DK89697A (da) Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed
ATE293972T1 (de) Behandlung von chronischen schmerzen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
NO20012849L (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
NZ501365A (en) Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma
DK0900085T3 (da) Behandling af overdreven aggression med olanzapin
DE69306260D1 (de) Behandlung von abwasser
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
EA199800818A1 (ru) Способ лечения бессонницы
ATE96129T1 (de) Behandlung von abwasser.